For how we live.
On 13 October the FDA extended Velphoro (sucroferric oxyhydroxide) to children aged 6 to 9 on dialysis and added a 250 mg chewable tablet, widening an iron-based binder previously limited to patients 9 and older.
A WHO data-set analysis shows how mobile and hospital teams split the load of hypertension, diabetes and epilepsy care during the war, while a separate study tracked dialysis capacity falling.
A study of 19,539 patients echoed the randomised CONVINCE trial — but it was observational, and several of its authors work for the dialysis company that owns the data.
In 1,362 Shanghai dialysis patients followed for over three years, hemoadsorption plus haemodialysis lowered all-cause mortality versus dialysis alone — a borderline result from an open-label trial.
PISCES randomised 1,228 haemodialysis patients in Canada and Australia. The headline hazard ratio of 0.57 counts every event, not just the first — and that choice explains part of the gap.